secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2022-11-28T23:59:59+00:00
Accession:  0001493152-22-033824
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience receives Nasdaq delisting notice for low stockholders' equity
-----------------------------------------------------------------------------

- Stockholders' equity of $1,287,224 as of Sept 30, 2022, below Nasdaq's $2.5M minimum requirement.
- Must submit a compliance plan to Nasdaq by January 7, 2023 (45 days from November 23, 2022).
- If plan accepted, Nasdaq may grant up to 180-day extension to regain compliance.
- Failure to regain compliance could result in delisting, with right to appeal to Nasdaq Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315222033824/0001493152-22-033824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315222033824/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-033824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer